NO20050570L - Nye forbindelser, preparater og fremgangsmater for behandling av inflammasjonssykdommer og -tilstander - Google Patents

Nye forbindelser, preparater og fremgangsmater for behandling av inflammasjonssykdommer og -tilstander

Info

Publication number: NO20050570L
Authority: NO; Norway
Prior art keywords: preparations; treatment; conditions; methods; inflammatory diseases
Prior art date: 2002-07-08

Application number

NO20050570A

Other languages

English (en)

Other versions

NO329885B1 (no

Inventor

Mladen Mercep

Milan Mesic

Linda Tomaskovic

Stribor Markovic

Oresta Makaruha

Visnja Poljak

Original Assignee

Pliva Istrazivacki Inst Doo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-08

Filing date

2005-02-02

Publication date

2005-03-04

2005-02-02 Application filed by Pliva Istrazivacki Inst Doo filed Critical Pliva Istrazivacki Inst Doo

2005-03-04 Publication of NO20050570L publication Critical patent/NO20050570L/no

2011-01-17 Publication of NO329885B1 publication Critical patent/NO329885B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Cardiology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Pain & Pain Management (AREA)
Biotechnology (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

NO20050570A 2002-07-08 2005-02-02 Nye forbindelser, fremgangsmate for fremstilling derav, anvendelse av forbindelsene samt farmasoytisk preparat omfattende en slik forbindelse NO329885B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US39467002P	2002-07-08	2002-07-08
PCT/HR2003/000037 WO2004005310A2 (en)	2002-07-08	2003-07-08	New compounds, compositions and methods for treatment of inflammatory diseases and conditions

Publications (2)

Publication Number	Publication Date
NO20050570L true NO20050570L (no)	2005-03-04
NO329885B1 NO329885B1 (no)	2011-01-17

Family

ID=30115752

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20050570A NO329885B1 (no)	2002-07-08	2005-02-02	Nye forbindelser, fremgangsmate for fremstilling derav, anvendelse av forbindelsene samt farmasoytisk preparat omfattende en slik forbindelse

Country Status (15)

Country	Link
US (1)	US7091187B2 (no)
EP (1)	EP1521764A2 (no)
JP (1)	JP4790263B2 (no)
CN (1)	CN100577681C (no)
AR (1)	AR040484A1 (no)
AU (1)	AU2003255851B2 (no)
BR (1)	BR0312634A (no)
CA (1)	CA2489402A1 (no)
IS (1)	IS7684A (no)
NO (1)	NO329885B1 (no)
NZ (1)	NZ537717A (no)
PL (1)	PL374731A1 (no)
RS (1)	RS20050008A (no)
RU (1)	RU2330858C2 (no)
WO (1)	WO2004005310A2 (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1483277A4 (en) *	2002-02-15	2007-10-03	Merckle Gmbh	CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, METHODS OF PREPARATION AND USE, AND FORMULATION AND PHARMACEUTICAL APPLICATIONS
TW200420573A (en) *	2002-09-26	2004-10-16	Rib X Pharmaceuticals Inc	Bifunctional heterocyclic compounds and methods of making and using same
KR20060002800A (ko) *	2003-03-05	2006-01-09	립-엑스 파마슈티칼즈, 인크.	이관능성 헤테로시클릭 화합물, 및 그의 제조 및 사용 방법
HRP20030324A2 (en) *	2003-04-24	2005-02-28	Pliva-Istra�iva�ki institut d.o.o.	Compounds of antiinflammatory effect
EP1682563A1 (en) *	2003-10-30	2006-07-26	Rib-X Pharmaceuticals, Inc.	Bifunctional macrolide heterocyclic compounds and mehtods of making and using the same
EP1699808A1 (en) *	2003-11-18	2006-09-13	Rib-X Pharmaceuticals, Inc.	Bifunctional macrolide heterocyclic compounds and methods of making and using the same
US8202843B2 (en)	2004-02-27	2012-06-19	Rib-X Pharmaceuticals, Inc.	Macrocyclic compounds and methods of making and using the same
MX2007001669A (es) *	2004-08-12	2007-04-10	Glaxosmithkline Zagreb	Uso de conjugados especificos celulares para el tratamiento de enfermedades inflamatorias del tracto gastrointestinal.
US20060183696A1 (en) *	2004-08-12	2006-08-17	Pliva-Istrazivacki Institut D.O.O.	Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract
ES2337915T3 (es) *	2004-10-27	2010-04-30	Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.	Conjugados con adtividad antiinflamatoria.
US8080529B2 (en) *	2005-01-13	2011-12-20	Glaxo Group Limited	Macrolides with anti-inflammatory activity
JP2008526945A (ja) *	2005-01-14	2008-07-24	グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ	抗炎症活性を有する９ａ−カルバモイルおよびチオカルバモイルアザライド
JP2009502838A (ja) *	2005-07-26	2009-01-29	メルクレ，ゲーエムベーハー	ピロリジンおよびインドリジン化合物のマクロライド接合体
US8282922B2 (en)	2007-05-29	2012-10-09	Novartis Ag	Method of treating an auto-inflammatory syndrome with a human IL-1β binding antibody
US8871728B2 (en)	2007-06-29	2014-10-28	Georgia Tech Research Corporation	Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof
WO2009006403A2 (en) *	2007-06-29	2009-01-08	Georgia Tech Research Corporation	Non-peptide macrocyclic histone deacetylase (hdac) inhibitors and methods of making and using thereof
AU2008316830B2 (en)	2007-10-25	2016-03-17	Cempra Pharmaceuticals, Inc.	Process for the preparation of macrolide antibacterial agents
US9072759B2 (en)	2008-10-24	2015-07-07	Cempra Pharmaceuticals, Inc.	Biodefenses using triazole-containing macrolides
US20100160351A1 (en) *	2008-12-19	2010-06-24	Nuon Therapeutics, Inc.	Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2010071865A1 (en)	2008-12-19	2010-06-24	Nuon Therapeutics, Inc.	Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
MX2011008074A (es)	2009-01-30	2011-08-17	Glaxo Group Ltd	Macrolido anti-inflamatorio.
US9937194B1 (en) *	2009-06-12	2018-04-10	Cempra Pharmaceuticals, Inc.	Compounds and methods for treating inflammatory diseases
ES2608285T3 (es)	2009-09-10	2017-04-07	Cempra Pharmaceuticals, Inc.	Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
WO2011032175A1 (en)	2009-09-14	2011-03-17	Nuon Therapeutics, Inc.	Combination formulations of tranilast and allopurinol and methods related thereto
WO2012034058A1 (en)	2010-09-10	2012-03-15	Cempra Pharmaceuticals, Inc.	Hydrogen bond forming fluoro ketolides for treating diseases
IN2014DN08939A (no)	2012-03-27	2015-05-22	Cempra Pharmaceuticals Inc
US20140256032A1 (en) *	2013-03-08	2014-09-11	Church & Dwight Co., Inc.	Light scattering sperm assesment device and method
CN105163785A (zh)	2013-03-14	2015-12-16	森普拉制药公司	用于治疗呼吸道疾病的方法及其制剂
RU2015138797A (ru)	2013-03-15	2017-04-24	Семпра Фармасьютикалс, Инк.	Конвергентные способы получения макролидных антибактериальных агентов
CN103641869B (zh) *	2013-12-30	2016-04-06	广州自远生物科技有限公司	一种泰拉菌素的合成方法
CA2995815C (en) *	2015-06-22	2021-08-24	The Brigham And Women's Hospital, Inc	Home evaluation of the quality of semen samples
GB201520419D0 (en)	2015-11-19	2016-01-06	Epi Endo Pharmaceuticals Ehf	Compounds
GB201608236D0 (en)	2016-05-11	2016-06-22	Fidelta D O O	Seco macrolide compounds
CA3060892A1 (en) *	2017-04-20	2018-10-25	Rising Tide Foundation	Azithromycin derivatives containing a phosphonium ion as anticancer agents
JP2020517748A (ja) *	2017-04-20	2020-06-18	ライジングタイドファウンデーション	抗がん剤としてホスホニウムイオンを含むアジスロマイシン誘導体
GB202404587D0 (en)	2024-03-28	2024-05-15	Epiendo Pharmaceuticals Ehf	Chemical forms

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4710495A (en)	1980-07-10	1987-12-01	Otsuka Pharmaceutical Co., Ltd.	Soft steroids having anti-inflammatory activity
US4474768A (en)	1982-07-19	1984-10-02	Pfizer Inc.	N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
ATE76311T1 (de)	1986-08-19	1992-06-15	Genentech Inc	Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und zytokinen.
HU198913B (en)	1987-09-03	1989-12-28	Pliva Pharm & Chem Works	Process for producing 10-dihydro-10-deoxo-11-aza-erythronolide a-derivatives and pharmaceutical compositions containing them as active components
LU87036A1 (fr) *	1987-11-04	1989-06-14	Oreal	Esters cycloaliphatiques insatures d'antibiotiques macrolidiques et lincosamidiques,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
SE9100341D0 (sv)	1991-02-04	1991-02-04	Astra Ab	Novel steroids
SE9100342D0 (sv)	1991-02-04	1991-02-04	Astra Ab	Novel steroid esters
GB9225923D0 (en)	1992-12-11	1993-02-03	Rhone Poulenc Rorer Ltd	New compositions of matter
JP2657982B2 (ja) *	1992-12-24	1997-09-30	ローン−プーラン・ロレ・リミテツド	新規ステロイド
US5965566A (en) *	1993-10-20	1999-10-12	Enzon, Inc.	High molecular weight polymer-based prodrugs
FR2719587B1 (fr)	1994-05-03	1996-07-12	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
EP0775489A4 (en)	1994-08-12	1998-05-06	Taisho Pharmaceutical Co Ltd	INTERLEUKIN-5 PRODUCTION INHIBITOR
CA2196879A1 (en)	1994-08-12	1996-02-22	Akihiko Hoshino	Interleukin-5 production inhibitor
FR2742757B1 (fr)	1995-12-22	1998-01-30	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
DE19616573C2 (de)	1996-04-25	1999-03-04	Pari Gmbh	Verwendung unterkritischer Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase
CA2252886C (en) *	1996-04-26	2008-02-12	Massachusetts Institute Of Technology	Three-hybrid screening assay
GB2321455A (en)	1997-01-24	1998-07-29	Norsk Hydro As	Lipophilic derivatives of biologically active compounds
HN1998000074A (es)	1997-06-11	1999-01-08	Pfizer Prod Inc	Derivados de macrolidos c-4 sustituidos
GB2327084A (en)	1997-07-08	1999-01-13	Merck & Co Inc	9a-Aza-3-ketolide antibiotics
EP0895999A1 (en)	1997-08-06	1999-02-10	Pfizer Products Inc.	C-4" substituted macrolide antibiotics
JP3530004B2 (ja)	1998-02-06	2004-05-24	株式会社日立ユニシアオートモティブ	吸入式投薬器
HRP980189B1 (en)	1998-04-06	2004-04-30	Pliva Pharm & Chem Works	Novel 15-membered lactams ketolides
AU4549999A (en) *	1998-06-08	1999-12-30	Advanced Medicine, Inc.	Novel polyene macrolide compounds and uses
US6043227A (en)	1998-08-19	2000-03-28	Pfizer Inc.	C11 carbamates of macrolide antibacterials
WO2000025776A1 (en)	1998-10-30	2000-05-11	Nitromed, Inc.	Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
IT1306205B1 (it)	1999-01-15	2001-05-30	Zambon Spa	Macrolidi ad attivita' antiinfiammatoria.
GB9909229D0 (en)	1999-04-23	1999-06-16	Glaxo Group Ltd	Enantiomers of mercapto lactones and processes for their synthesis
HRP20010018A2 (en)	2001-01-09	2002-12-31	Pliva D D	Novel anti-inflammatory compounds
US20040186063A1 (en)	2002-02-15	2004-09-23	Hans-Jurgen Gutke	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
EP1483277A4 (en)	2002-02-15	2007-10-03	Merckle Gmbh	CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, METHODS OF PREPARATION AND USE, AND FORMULATION AND PHARMACEUTICAL APPLICATIONS
AU2003211113B2 (en)	2002-02-15	2007-08-09	Merckle Gmbh	Antibiotic conjugates
WO2003070173A2 (en)	2002-02-15	2003-08-28	Sympore Gmbh	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof

2003
- 2003-07-08 WO PCT/HR2003/000037 patent/WO2004005310A2/en not_active Ceased
- 2003-07-08 EP EP03762825A patent/EP1521764A2/en not_active Withdrawn
- 2003-07-08 NZ NZ537717A patent/NZ537717A/en not_active IP Right Cessation
- 2003-07-08 US US10/615,716 patent/US7091187B2/en not_active Expired - Fee Related
- 2003-07-08 RS YUP-2005/0008A patent/RS20050008A/sr unknown
- 2003-07-08 CA CA002489402A patent/CA2489402A1/en not_active Abandoned
- 2003-07-08 AU AU2003255851A patent/AU2003255851B2/en not_active Ceased
- 2003-07-08 RU RU2005103226/04A patent/RU2330858C2/ru not_active IP Right Cessation
- 2003-07-08 CN CN03816093A patent/CN100577681C/zh not_active Expired - Fee Related
- 2003-07-08 BR BR0312634-0A patent/BR0312634A/pt not_active IP Right Cessation
- 2003-07-08 JP JP2004519021A patent/JP4790263B2/ja not_active Expired - Fee Related
- 2003-07-08 PL PL03374731A patent/PL374731A1/xx unknown
- 2003-07-10 AR AR20030102488A patent/AR040484A1/es unknown
2005
- 2005-02-02 NO NO20050570A patent/NO329885B1/no not_active IP Right Cessation
- 2005-02-03 IS IS7684A patent/IS7684A/is unknown

Also Published As

Publication number	Publication date
CN100577681C (zh)	2010-01-06
JP2005535654A (ja)	2005-11-24
AR040484A1 (es)	2005-04-06
HK1082256A1 (zh)	2006-06-02
US20040014685A1 (en)	2004-01-22
JP4790263B2 (ja)	2011-10-12
RU2330858C2 (ru)	2008-08-10
BR0312634A (pt)	2005-05-10
US7091187B2 (en)	2006-08-15
RS20050008A (sr)	2007-06-04
WO2004005310A3 (en)	2004-04-22
CN1692123A (zh)	2005-11-02
AU2003255851B2 (en)	2009-07-23
PL374731A1 (en)	2005-10-31
CA2489402A1 (en)	2004-01-15
AU2003255851A1 (en)	2004-01-23
IS7684A (is)	2005-02-03
EP1521764A2 (en)	2005-04-13
NZ537717A (en)	2006-04-28
NO329885B1 (no)	2011-01-17
RU2005103226A (ru)	2005-11-20
WO2004005310A2 (en)	2004-01-15

Publication	Publication Date	Title
NO20050570L (no)	2005-03-04	Nye forbindelser, preparater og fremgangsmater for behandling av inflammasjonssykdommer og -tilstander
NO20053077D0 (no)	2005-06-23	Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
NO20043442L (no)	2004-10-19	Nye substituerte benzimidazol-doseringsformer og fremgangsmater for anvendelse av samme
NO20052760D0 (no)	2005-06-07	Fremgangsmate for behandling av kreft og beslektede fremgangsmater.
NO20040072L (no)	2005-03-08	Nye substituerte benzimidazol-doseringsformer og fremgangsmate for anvendelse av samme
NO20014960L (no)	2001-12-10	Nye fremgangsmåter for behandling
NO20031442L (no)	2003-05-26	Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
SE531352C8 (sv)	2009-05-19	Spiroalkanderivat och användning av dessa föreningar för behandling av artrit, cancer, kardiovaskulära sjukdomar, hudsjukdomar och inflammatoriska och allergiska tillstånd
IS2722B (is)	2011-03-15	1, 2, 3, 4- Tetrasetin indól til meðhöndlunar á öndunarfærasjúkdómum
NO20044054L (no)	2004-11-24	Administrering av midler for behandling av betennelse
DK1663978T3 (da)	2008-04-07	Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
NO20041882L (no)	2004-05-07	Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
NO20052894D0 (no)	2005-06-14	4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
DE602005023172D1 (de)	2010-10-07	Hydantoinderivate zur behandlung von entzündlichen erkrankungen
IS8071A (is)	2005-10-13	Aðferð við meðhöndlun á hnútahersli, fitudreyra og tengdum ástands tegundum og lyfjafræðilegum samsetningum
NO20014950D0 (no)	2001-10-11	Nye behandlingsmetoder
EA200500098A1 (ru)	2005-08-25	Лекарственное средство и способ лечения патологического синдрома
NO20043246L (no)	2004-08-02	Nye fremgangsmater til diagnose og behandling av tumorer
NO20014648L (no)	2001-11-22	Forbindelser og metoder for behandling av astma, allergi og inflammatoriske sykdommer
IS7699A (is)	2005-02-17	Afleiður af díoxan-2-alkýl karbamötum, framleiðslu aðferð þeirra og notkun við meðferð sjúkdóma
IS7444A (is)	2004-09-13	Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum
IL175535A (en)	2016-03-31	Compositions for treatment of neurodegenerative diseases
NO20045554L (no)	2004-12-20	Fremgangsmate for behandling av diabetes
NO20054598D0 (no)	2005-10-06	Beta-karboliner anvendbare for behandling av betennelsessykdommer
EP1611120A4 (en)	2008-04-23	NEW M THODES FOR THE TREATMENT OF INFLAMMATORY DISEASES

Legal Events

Date	Code	Title	Description
2012-03-26	MM1K	Lapsed by not paying the annual fees